PARABDRUGS

Parabolic Drugs Limited has informed the Exchange regarding Change in Auditors of the company.

Parabolic Drugs Limited has informed the Exchange regarding Resignation of Mr VK Jindal and associates as statutory auditors of the company w.e.f. October 01, 2018.

Parabolic Drugs Limited has informed the Exchange regarding Change in Auditors of the company.Pursuant to Section 139 of Companies Act, 2013 and Rules made thereunder, it is mandatory for the Company to rotate the Statutory Auditor on completion of maximum term permitted under the said Section. Accordingly, based on the recommendation of the Board of Directors and Audit Committee of the Company, the members of the Company in their 21st Annual General Meeting held on 29th September, 2017 appointed V.K. Jindal & Associates, Chartered Accountants as Statutory Auditors of the

Parabolic Drugs Limited has informed the Exchange regarding Appointment of Mr Ashok Kumar Jindal as Chief Financial Officer of the company w.e.f. May 10, 2017. Mr. Ashok Kumar Jindal has a rich experience of around forty years. Mr. Jindal has handled various accounting matters. He has also handled responsibilities with respect to sales tax, Insurance, Banking etc. He has a dynamic experience of handling various matters concerning the above mentioned spheres from which the organization will benefit vastly. You are requested to take the above said information on your record a

Parabolic Drugs Limited has informed the Exchange regarding Appointment of Mr Ashok Kumar Jindal as Chief Financial Officer of the company w.e.f. May 10, 2017.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 13, 2016: (1) Resignation of Ms Mallika Seth from the post of Company Secretary of the Company.

Parabolic Drugs Limited has informed the Exchange that Mr. Balwan Bansal, Director, has resigned from the Board of Director of the Company w.e.f. February 12, 2015.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors in its meeting held on November 14, 2014: 1. Appointed Mrs. Vandana Singla, as an Independent Director of the Company.

Parabolic Drugs Limited has informed the Exchange that Mr Balbir Singh Bhasin Nominee Director of State Bank of India (SBI) has resigned from the Board of Directors of the Company w.e.f. July 02, 2014.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors of the Company at its Meeting held on February 13, 2013:(1) Approved the resignation of Mr. Gurpeet Singh Sandhu from the Directorship of the Company.

Parabolic Drugs Limited has informed the Exchange that Mr. Inder Bir Singh Passi and Mr. Koppisetty Srinivas has resigned from the Directorship of the Company. Further, Mr. Balwan Bansal has been appointed as an Additional Director on the Board of Directors of the Company.

Parabolic Drugs Limited has informed the Exchange that the members of the Company at its Annual General Meeting held on September 29, 2011: (1) Appointed Mr. Manmohan Lal Sarin as a Director in place of Mr. Pardeep Diwan, who retired by rotation in accordance with the provisions of Articles of Association of the Company; (2) Approved the appointments of Mr. Gurpreet Singh Sandhu and Mr. Nikhil Goel as the Directors of the Company w.e.f September 29, 2011. (3) Approved the appointment of Mr. Gurpreet Singh Sandhu as the Executive Director of the Company w.e.f November 01, 2010 to October 31, 20

Parabolic Drugs Limited has informed the Exchange that the Board of Directors in its meeting held on November 08, 2010: (1) Approved the Resignation of Dr. Deepali Gupta from the directorship of the Company w.e.f. November 08, 2010. (2) Approved the Appointments of Mr. Gurpeet Singh Sandhu and Mr. Nikhil Goel as the Additional Directors of the Company w.e.f. November 08, 2010.(3) Recommended the Appointment of Mr. Gurpreet Singh Sandhu as the Whole Time Director of the Company w.e.f. November 08, 2010.